Brian Druker
Director/Board Member bei AMGEN INC.
Vermögen: 2 Mio $ am 31.03.2024
Aktive Positionen von Brian Druker
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| AMGEN INC. | Director/Board Member | 23.05.2018 | - |
| Independent Dir/Board Member | 23.05.2018 | - | |
| VINCERX PHARMA, INC. | Director/Board Member | 23.12.2020 | - |
| Independent Dir/Board Member | 23.12.2020 | - | |
| Oregon Health & Science University | Director/Board Member | 01.07.2007 | - |
| Corporate Officer/Principal | 01.07.2000 | - | |
The Burroughs Wellcome Fund
 The Burroughs Wellcome Fund Investment Trusts/Mutual FundsMiscellaneous The Burroughs Wellcome Fund is a private foundation located in Research Triangle Park, NC. The private company's mission is to serve and strengthen society by nurturing a diverse group of leaders in biomedical sciences to improve human health through education and powering discovery in frontiers of greatest need. The CEO of the company is Louis J. Muglia. | Director/Board Member | - | - |
| OHSU Knight Cancer Institute | Director/Board Member | 01.07.2007 | - |
Karriereverlauf von Brian Druker
Ehemalige bekannte Positionen von Brian Druker
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
MolecularMD Corp.
 MolecularMD Corp. Medical/Nursing ServicesHealth Services MolecularMD Corp. develops and commercializes molecular diagnostics for oncology applications. Its tests are designed to assist pharmaceutical companies with selection, monitoring and management of patients treated with molecularly-targeted cancer therapies. The firm integrates gold-standard and innovative platform technologies with custom clinical assay design and validation to accelerate all phases of clinical development, including FDA approval and commercialization of in vitro companion diagnostic tests for novel anticancer agents. The company was founded by Brian Druker, Sheridan G. Snyder, and Chad D. Galderisi in 2005 and is headquartered in Portland, OR. | Founder | 01.01.2005 | - |
| BLUEPRINT MEDICINES CORPORATION | Founder | 04.10.2008 | - |
Ausbildung von Brian Druker
| University of California San Diego | Doctorate Degree |
Statistik
International
| Vereinigte Staaten | 9 |
Operativ
| Director/Board Member | 5 |
| Founder | 2 |
| Independent Dir/Board Member | 2 |
Sektoral
| Health Technology | 4 |
| Consumer Services | 3 |
| Miscellaneous | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| AMGEN INC. | Health Technology |
| BLUEPRINT MEDICINES CORPORATION | Health Technology |
| VINCERX PHARMA, INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
The Burroughs Wellcome Fund
The Burroughs Wellcome Fund Investment Trusts/Mutual FundsMiscellaneous The Burroughs Wellcome Fund is a private foundation located in Research Triangle Park, NC. The private company's mission is to serve and strengthen society by nurturing a diverse group of leaders in biomedical sciences to improve human health through education and powering discovery in frontiers of greatest need. The CEO of the company is Louis J. Muglia. | Miscellaneous |
MolecularMD Corp.
MolecularMD Corp. Medical/Nursing ServicesHealth Services MolecularMD Corp. develops and commercializes molecular diagnostics for oncology applications. Its tests are designed to assist pharmaceutical companies with selection, monitoring and management of patients treated with molecularly-targeted cancer therapies. The firm integrates gold-standard and innovative platform technologies with custom clinical assay design and validation to accelerate all phases of clinical development, including FDA approval and commercialization of in vitro companion diagnostic tests for novel anticancer agents. The company was founded by Brian Druker, Sheridan G. Snyder, and Chad D. Galderisi in 2005 and is headquartered in Portland, OR. | Health Services |
| OHSU Knight Cancer Institute |
- Börse
- Insiders
- Brian Druker
- Erfahrung
